RVMD Stock Posts

4/16/2026 11:17:52 AM

Unusual Option Volume

RVMD Revolution Medicines154.60+2.06 (+1.4%)

Revolution Medicines trades 6,342 contracts. The company has the following event: 2026 American Association for Cancer Research (AACR) Annual Meeting on Apr 18, 2026. News: Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes

4/15/2026 10:22:12 AM

Unusual Option Volume

RVMD Revolution Medicines149.02+2.01 (+1.4%)

Revolution Medicines trades 3,476 contracts. The company has the following event: 2026 American Association for Cancer Research (AACR) Annual Meeting on Apr 18, 2026. News: Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes

4/14/2026 10:22:13 AM

Unusual Option Volume

RVMD Revolution Medicines138.51+2.21 (+1.6%)

Revolution Medicines trades 3,170 contracts. The company has the following event: 2026 American Association for Cancer Research (AACR) Annual Meeting on Apr 18, 2026. News: Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

4/13/2026 4:30:54 PM

RVMD #RevolutionMedicines stock declines -1.9% in after hours trading. See the latest news.

After Hours Decliner

RVMD Revolution Medicines136.30+39.87+41.4%

After Hours:133.73-2.57 (-1.9%)

Globe NewswireMon, 13-Apr 4:01 PM

4/13/2026 10:22:40 AM

Unusual Option Volume

RVMD Revolution Medicines131.81+35.38 (+36.7%)

Revolution Medicines trades 10,363 contracts. The company has the following event: 2026 American Association for Cancer Research (AACR) Annual Meeting on Apr 18, 2026. News: Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

4/13/2026 10:17:00 AM

RVMD 133.88+37.45 (+38.8%)Revolution Medicines

ATM straddle for 17-Apr-26 expiration returned a positive 285.4% from the previous business day
The upside wing (25 delta calls) gained 1372.5%
Downside put (25 delta puts) lost -98.9%
The company has the following event: 2026 American Association for Cancer Research (AACR) Annual Meeting on Apr 18, 2026.
The option volume for 17-Apr-26 expiration is 5,993
News: Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Load Earlier Posts

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software